Drug Markers Respond to Concerns Over Specialty-Pharmacy Use; More News About Valeant

Drug Makers Respond to Concerns Over Specialty-Pharmacy Use

Wall Street Journal-18 hours ago

Drug makers on Wednesday moved to allay concerns about their usage of specialty pharmacies, as questions swirl about the relationships between some ...

Drug makers respond to specialty pharmacy worry
MarketWatch-18 hours ago

Allergan Issues Statement On Specialty Pharmacy Utilization
PR Newswire (press release)-21 hours ago

Allergan (AGN) Says it Doesn't Rely on Specialty Pharmacy ...
StreetInsider.com-21 hours ago

Valeant Pharmaceuticals rout hammers drug stocks
In-Depth-The Australian Financial Review-18 hours ago

Valeant, Allergan & Teva: Compelling Valuations, Not Compelling ...
Blog-Barron's (blog)-19 hours ago

Barron's (blog)

The Australian Financial Review

The Weather Space

Orange County Business Journal

Explore in depth (66 more articles)


The fraud allegations against Valeant exposed an industry secret ...Specialty pharmacies in spotlight as Valeant ties questioned

Reuters-12 hours ago

TO) have put a spotlight on the little-known and fast-growing specialtypharmacy industry. Shares of Valeant fell 19 percent on Wednesday after influential ...

Business Insider-15 hours ago

Bill Ackman purchases 2M shares of Valeant
Highly Cited-CNBC-18 hours ago

Valeant, Philidor, R&O: What's In a Website?
Blog-Wall Street Journal (blog)-17 hours ago

Valeant Pharmaceuticals Philidor Rx Unit Says It Has A Right To ...
In-Depth-Forbes-11 hours ago

Valeant Half the Stock It Used to Be as Citron Report Sinks Shares
Blog-Barron's (blog)-22 hours ago